News Release

Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction
Shieh-Yueh Yang, Heui-Chun Liu, Chin-Yi Lin, Ming-Jang Chiu, Ta-Fu Chen, Chin-Hsien Lin and Hsin-...
more
Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
SY Yang, HC Liu and WP Chen Neurol Therapy (2020) https://link....
more
Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
CH Lin, SI Chiu, TF Chen, JS Roger Jang  and MJ Chiu Int. J. Mol. Sci. 2020, 21(18), 6914...
more
Plasma Biomarkers Ascertained with Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review
PU Tang, IH Wu, IH Lao, Wai Leong and CJ Hu Innovations in Digital Health, Diagnostics, and...
more
The Validation of Multifactor Model of Plasma Aβ42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease
FB Jiao, Fang Yi, YY Wang, SZ Zhang, YJ Guo, WJ Du, Ya Gao, JJ Ren, HF Zhang, LX Liu, HF Song and...
more

Pages